Related content

The importance of non-transferrin bound iron in disorders of iron metabolism

By Breuer W.   Hershko C.   Cabantchik Z.I.  

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 185-192

Elsevier

Access to resources Recommend Favorite

Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy

By Breuer W.   Ermers M.J.J.   Pootrakul P.   Abramov A.   Hershko C.   Ioav Cabantchik Z.  

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 241-242

Elsevier

Access to resources Recommend Favorite

Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy

By Breuer W.   Ermers M.J.J.   Pootrakul P.   Abramov A.   Hershko C.   Ioav Cabantchik Z.  

Transfusion Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 241-242

Elsevier

Access to resources Recommend Favorite

The Effect of Transferrin Polymorphisms on Iron Metabolism

By Lee P.L.   Ho N.J.   Olson R.   Beutler E.  

Blood Cells, Molecules, and Diseases, Vol. 25, Iss. 6, 1999-12 ,pp. : 374-379

Academic Press

Access to resources Recommend Favorite

Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in -thalassemia intermedia

By Domenica Cappellini M.   Tavazzi D.   Duca L.   Marelli S.   Fiorelli G.  

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 245-246

Elsevier

Access to resources Recommend Favorite